The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of pembrolizumab in people with HIV and cancer.
 
Thomas S. Uldrick
Research Funding - Bayer (Inst); Celgene (Inst); Merck (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - As an employee of the U.S. Government, I have provisional patent application regarding methods for the treatment of Kaposi’s sarcoma and KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers (Inst)
 
Priscila Hermont Goncalves
Research Funding - Bristol-Myers Squibb; Daiichi Sankyo; FORMA Therapeutics; Genentech; Immunocore; Incyte; Karyopharm Therapeutics; Pfizer; Presage Biosciences; Regeneron; Syndax; Vaccinex
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Xencor
 
Mohammad Maher Abdul Hay
Honoraria - Takeda
Consulting or Advisory Role - Takeda
Speakers' Bureau - Takeda
 
Alisa J Claeys
No Relationships to Disclose
 
Brinda Emu
Honoraria - TheraTech
Consulting or Advisory Role - TheraTech
Travel, Accommodations, Expenses - TheraTech
 
Marc S. Ernstoff
Stock and Other Ownership Interests - GE Healthcare
Consulting or Advisory Role - Bristol-Myers Squibb; Celyad; EMD Serono; Lion Biotechnologies; Omniseq
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merrimack (Inst)
 
Lawrence Fong
Consulting or Advisory Role - Atreca; BioAtla; Bolt Biotherapeutics; IDEAYA Biosciences; Nutcracker Therapeutics, Inc.; TeneoBio
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Judith C Kaiser
No Relationships to Disclose
 
Holbrook Edwin Kohrt
No Relationships to Disclose
 
Andreanne Lacroix
No Relationships to Disclose
 
Steve Young Lee
No Relationships to Disclose
 
Lisa Lundgren
Stock and Other Ownership Interests - Amgen; Celgene; Celldex
 
Kathryn Anne Lurain
Research Funding - Celgene (Inst); Genentech (Inst)
 
Christopher Parsons
No Relationships to Disclose
 
Sharavi Peeramsetti
No Relationships to Disclose
 
Ramya Ramaswami
Research Funding - Celgene (Inst); Genentech (Inst)
 
Elad Sharon
No Relationships to Disclose
 
Chia-Ching Jackie Wang
Research Funding - Bristol-Myers Squibb
 
Robert Yarchoan
Research Funding - Celgene (Inst); Genentech (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to increase in immune surface markers by pomalidomide, lenalidomide and related drugs in patients with KSHV-associated diseases (Inst); Patent(s) on the treatment of HIV and hepatitis virus with an antiviral drug and a vaccine to prevent resistance (Inst); Patents on the treatment of Kaposi sarcoma with IL-12 (Inst); Various patents including patents on anti-HIV therapies and soluble IL-2 receptor; mostly expired. (Inst); Various patents on vasostatin, KSHV vIL-6, internalization of surface markers, calreticulin, and calreticulin fragments (Inst)
 
Martin A. Cheever
No Relationships to Disclose